Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02652572 · ClinicalTrials.gov registry record · Phase 1
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
A Phase 1 study of Venous Leg Ulcer, sponsored by Xequel Bio.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 3
- Study locations
NCT02652572 is a Phase 1 study of Venous Leg Ulcer that has completed, run by Xequel Bio. The registered enrollment target is 10 participants, below the 245-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT02652572, a Phase 1 study of Venous Leg Ulcer, has completed, sponsored by Xequel Bio.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to determine the systemic exposure of Granexin® gel after topical application to human subjects' venous leg ulcers.
Conditions Studied
Interventions
- DRUG Granexin
Study Locations (3)
Georgia
- Aiyan Diabetes Center - Augusta
South Carolina
- Spartanburg Regional Healthcare System - Spartanburg
Virginia
- Salem VA Medical Center - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02652572
The ClinicalTrials.gov registry entry for NCT02652572 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (96% lower). The listed sponsor is Xequel Bio, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Venous Leg Ulcer appearing as the primary indexed condition, and to 1 intervention - of which Granexin is the first listed.
NCT02652572 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Georgia, South Carolina, Virginia.
Frequently Asked Questions
What is clinical trial NCT02652572 about?
NCT02652572 is a clinical study titled "Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers". The purpose of this study is to determine the systemic exposure of Granexin® gel after topical application to human subjects' venous leg ulcers.
What is the current status of trial NCT02652572?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2015-09. Estimated completion is 2018-05.
What conditions does trial NCT02652572 study?
This clinical trial studies the following conditions: Venous Leg Ulcer.
What interventions are being tested in trial NCT02652572?
The interventions under investigation include: Granexin (DRUG).
Who is sponsoring clinical trial NCT02652572?
This trial is sponsored by Xequel Bio, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02652572 being conducted?
This trial has 3 study locations across Georgia, South Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · Phase 4
-
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.